Population Genomics

National Strategy and Implementation

Published Year: 2019
SKU: BH00731SA


Online Access for One Person. Permission to Print

A quick peek into the report

Report Description

The aim of the population genomic initiatives implemented across the globe is to develop the biobank of genomic datasets facilitat

Population genomics initiatives launched in several nations have significantly transformed the entire healthcare industry. With the advancements in technology and the allocation of government funding for the implementation of these programs has profoundly reshaped the current clinical practice. The decreasing cost of genome sequencing and the development of advanced of bioinformatics tools for the analysis of genomic data has facilitated the development of personalized treatment modules. The increased focus of the government for the implementation of population-based sequencing programs has fostered the rapid growth of precision medicine in the medical industry.

The aim of the population genomic initiatives implemented across the globe is to develop the biobank of genomic datasets facilitating the understanding of interaction between the gene and the phenotypic expression. Population genomics initiatives such as All of Us and UK 100K Genomes Project have been initiated to enhance the adoption of genomic medicine and consequentially increasing the awareness among patients and healthcare providers.

Key Questions Answered in this Report

How does the emergence of population-based sequencing initiatives is transforming the current clinical practice?

The answers to the following key questions can be derived from this report:

•    How does the emergence of population-based sequencing initiatives is transforming the current clinical practice?
•    Which are the ongoing initiatives that have been implemented by different regions such as North America, Europe, Asia-Pacific and Middle East to promote the acceptance of genomic medicine?
•    What is the role of key stakeholders in aligning the fortune of population genomics?
•    What are the innovative strategies adopted across the world for implementation of population genomics?
•    What is the plausible market penetration strategy for the precision medicine market?
•    What are the current value assessment and the future perspective of population genomics initiatives?
•    What is the scope of industrial participation in the ongoing population genomic initiatives?

Market Overview

The aim of the population genomic initiatives implemented across the globe is to develop the biobank of genomic datasets facilitat

This strategic report provides a multidimensional view of the strategic evolution of the ongoing population genomic initiatives.  The purpose of the study is to gain a holistic view of the active population-based sequencing projects implemented in several countries. The report contains the analysis of various such as recent trends, technological advancements, reimbursement scenario, and national level initiatives across the globe influencing the adoption of population genomics. The scope of this report is centered upon conducting a detailed study of the strategies, best R&D practices across the globe, and understanding the focus of eminent stakeholders contributing in augmenting the growth of population genomics initiative.

This research report aims at answering various aspects of the population genomics initiatives with the help of the key strategies adopted by different nations for the successful implementation of the program. The report also covers the current status and future perspective of the national population-based sequencing programs that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key players and recent developments taking place in this market.

The research study highlights the key initiatives implemented by several nations across the globe for the whole genome sequencing of its populations. Moreover, the study includes detailed analysis of key trends in multiple geographical regions, industrial partnerships in each region, key strategies and adopted by various nations and future perspectives of the initiatives.

Table of Contents

Download this TOC  

Request a Sample

1 Population Genomics: National Strategy and Implementation

                  Figure 1.1:  Population Genomics Initiative Workflow.
         1.1    Public Health and Genomics
                  Figure 1.2:  Objectives of Public Health Genomics
                  Table 1.1:   Challenges in Public Health Genomics
         1.2    Evolution of Population Genomics
                  Figure 1.3:  Evolution of Population Genomics

2 Regional Strategy for Implementation of Population Genomics Projects

         2.1    North America
                  2.1.1    U.S.
                                    Table 2.1:  Population Genomic Initiatives in U.S.
                                    Table 2.2:  Funding Allocated to Different Agencies
                  2.1.2    Canada
                                    Table 2.3:  Population Genomic Initiatives in Canada
                                    Table 2.4:  National and International Initiatives in Canada
                                    Table 2.5:  Ongoing Population Genomics Program
                        Population Genomics Program
         2.2    Europe
                                    Table 2.6:  European Initiatives for Implementation of Population Genomics
                  2.2.1    The U.K.
                                    Table 2.7:  Population Genomic Initiatives in U.K.
                        Industrial Partnership Directing the Course of Genomic Medicine
                                    Table 2.8:  Key Investments Driving Genomic Medicine in the U.K.
                                    Table 2.9:  Genomic Medicine Centers in the U.K.
                  2.2.2    Estonia
                                    Table 2.10:  Population Genomic Initiatives in Estonia
                  2.2.3    Germany
                                    Table 2.11:  Population Genomic Initiatives in Germany
                  2.2.4    France
                                    Table 2.12:  Population Genomic Initiatives in China
                                    Table 2.13:  French Genomic Platform
                  2.2.5    Ireland
                                    Table 2.14:  Population Genomic Initiatives in Ireland
                  2.2.6    The Netherlands
                                    Table: 2.15  Population Genomic Initiatives in the Netherlands
                  2.2.7    Denmark
                                    Table 2.16:  Population Genomic Initiatives in Denmark
         2.3    Asia Pacific
                  2.3.1    Japan
                                    Table 2.17:  Population Genomic Initiatives in Japan
                  2.3.2    China
                                    Table 2.18:  Population Genomic Initiatives in China
                  2.3.3    Australia
                                    Table 2.19:   Population Genomic Initiatives in Australia
         2.4    Middle East
                  2.4.1    Saudi Arabia
                                    Table 2.20:   Population Genomic Initiatives in Saudi Arabia
                  2.4.2    Qatar
                                    Table 2.21:   Population Genomic Initiatives in Qatar
                  2.4.3    Turkey
                                    Table 2.22:   Population Genomic Initiatives in Turkey
                  2.4.4    Dubai
                                    Table 2.23:   Population Genomic Initiatives in Dubai

3 Innovative Strategies Adopted Across the World for Implementation of Population Genomics

         Figure 3.1:  Member of the GENE Consortium
         3.1    Collaborative Implementation
         3.2    Implementation of Cross-Border Genome Data Bank
         3.3    Focused Implementation Program
         3.4    Involvement of the Private Sector

4 Impact on Healthcare Industry

Figure 4.1: Impact of Population Genomics on Healthcare Industry

5 Population Genomics: Current State and Perspectives

         Figure 5.1:   Current Status of Population Genomics
         Figure 5.2:   Future Perspective of Population Genomics
         5.1    Growing Public-Partnerships
         5.2    Decrease in Sequencing Cost
                                    Figure 5.3:   Fall in Genome Sequencing Cost
         5.3    Government Initiatives for Development of Framework and Reimbursement Policy
         5.4    Involvement of the Private Sector
         5.5    Increased Population Engagement and Data Management

6 Industrial Perspective for Population Genomics

Figure 6.1: Participation of Industry in Population Genomics

You may also like

Published Year: 2019

Global Clinical Decision Support Systems (CDSS) Market: Focus on Product Type, Model, User Interactivity, Application, and Regional Adoption – Analysis and Forecast, 2019-2028

The Global Clinical Decision Support Systems Market Report by BIS Research projects the market...

Published Year: 2019

Global Single Cell Multi-Omics Market: Focus on Global Single Cell Multi-Omics Market by Product, Type, Workflow, End-User 15 Countries Mapping, and Competitive Landscape - Analysis and Forecast, 2019-2025

The global single cell multi-omics industry analysis by BIS Research projects that the market...

Published Year: 2019

Global Next-Generation Sequencing Market: Focus on Products and Services, Applications, Technology, 18 Countries Data, Industry Insights, and Competitive Landscape – Analysis and Forecast, 2019-2024

In 2018, the global next-generation sequencing market was valued at $4.93 billion and is...

Published Year: 2019

Global Precision Medicine Market: Focus on Precision Medicine Ecosystem, Applications, 13 Countries Mapping, and Competitive Landscape - Analysis and Forecast, 2018-2028

The global precision medicine market is anticipated to reach $216.75 billion by 2028,...

Published Year: 2018

Strategic Evaluation of Precision Medicine: Country Analysis for Emerging Opportunities

In 2017, the global precision medicine market accounted for $48.9 billion, which is expected...


Population Genomics

National Strategy and Implementation